Scientists track mental health drugs from mom to baby
NCT ID NCT05766007
Summary
This study aims to understand how pregnancy and breastfeeding affect long-acting injectable antipsychotic medications used for conditions like schizophrenia. Researchers will measure drug levels in the blood of pregnant and breastfeeding women, and also check how much of the medication passes to the baby through the placenta or breast milk. The goal is to gather information to help doctors and patients make safer, more informed treatment decisions during and after pregnancy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Federal Medical Centre
RECRUITINGMakurdi, Benue State, Nigeria
Contact Email: •••••@•••••
-
Federal Neuropsychiatric Hospital
RECRUITINGKaduna, Kaduna State, Nigeria
Contact Email: •••••@•••••
-
Federal Neuropsychiatric Hospital
RECRUITINGYaba, Lagos, Nigeria
Contact Email: •••••@•••••
-
Neuropsychiatric Hospital
RECRUITINGAbeokuta, Ogun State, Nigeria
Contact Email: •••••@•••••
-
Neuropsychiatric Specialist Hospital
RECRUITINGAkure, Ondo State, Nigeria
Contact Email: •••••@•••••
-
Obafemi Awolowo University Teaching Hospital
NOT_YET_RECRUITINGIle-Ife, Osun State, Nigeria
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.